Table of Contents Author Guidelines Submit a Manuscript
International Journal of Microbiology
Volume 2016, Article ID 9752097, 7 pages
http://dx.doi.org/10.1155/2016/9752097
Research Article

BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients

1Medical research Unit, School of Medicine, University of Al-Nahrain, Baghdad 10066, Iraq
2Medical Technical Institute, Baghdad 10066, Iraq
3Biotechnology Department, School of Science, University of Baghdad, Baghdad 10066, Iraq
4Biology Department, School of Science, University of Al-Mustansiriyah, Baghdad 10066, Iraq

Received 3 December 2015; Revised 10 February 2016; Accepted 15 February 2016

Academic Editor: Carla R. Arciola

Copyright © 2016 Haidar A. Shamran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Comoli, M. Cioni, S. Basso et al., “Immunity to polyomavirus BK infection: immune monitoring to regulate the balance between risk of BKV nephropathy and induction of alloimmunity,” Clinical and Developmental Immunology, vol. 2013, Article ID 256923, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. L. C. Paul, “Chronic allograft nephropathy: an update,” Kidney International, vol. 56, no. 3, pp. 783–793, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. C. A. Smith, T. Farrah, and R. G. Goodwin, “The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death,” Cell, vol. 76, no. 6, pp. 959–962, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Falini, S. Pileri, G. Pizzolo et al., “CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy,” Blood, vol. 85, no. 1, pp. 1–14, 1995. View at Google Scholar · View at Scopus
  5. B. Werner, C. Massone, H. Kerl, and L. Cerroni, “Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin,” Journal of Cutaneous Pathology, vol. 35, no. 12, pp. 1100–1107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Oflazoglu, I. S. Grewal, and H. Gerber, “Targeting CD30/CD30L in oncology and autoimmune and inflammatory diseases,” in Therapeutic Targets of the TNF Superfamily, N. Back, I. R. Cohen, A. Lajtha, J. D. Lambris, and R. Paoletti, Eds., Advances in Experimental Medicine and Biology, pp. 174–185, Springer, New York, NY, USA, 2009. View at Publisher · View at Google Scholar
  7. R. W. Gedrich, M. C. Gilfillan, C. S. Duckett, J. L. Van Dongen, and C. B. Thompson, “CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins,” The Journal of Biological Chemistry, vol. 271, no. 22, pp. 12852–12858, 1996. View at Publisher · View at Google Scholar · View at Scopus
  8. R. H. Arch and C. B. Thompson, “4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB,” Molecular and Cellular Biology, vol. 18, no. 1, pp. 558–565, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. N. S. Chandel, P. T. Schumacker, and R. H. Arch, “Reactive oxygen species are downstream products of TRAF-mediated signal transduction,” The Journal of Biological Chemistry, vol. 276, no. 46, pp. 42728–42736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Del Prete, M. De Carli, M. M. D'Elios et al., “CD30-mediated signaling promotes the development of human T helper type 2-like T cells,” The Journal of Experimental Medicine, vol. 182, no. 6, pp. 1655–1661, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Gilffillan, P. J. Noel, E. R. Podack, S. L. Reiner, and C. B. Thompson, “Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines,” Journal of Immunology, vol. 160, no. 5, pp. 2180–2187, 1998. View at Google Scholar · View at Scopus
  12. O. Josimovic-Alasevic, H. Durkop, R. Schwarting, E. Backe, H. Stein, and T. Diamantstein, “Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay,” European Journal of Immunology, vol. 19, no. 1, pp. 157–162, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Shooshtarizadeh, A. Mohammadali, S. Ossareh, and Y. Ataipour, “Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant,” Experimental and Clinical Transplantation, vol. 11, no. 3, pp. 229–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Nakao, Y. Nagake, A. Okamoto, H. Ichikawa, M. Yamamura, and H. Makino, “Serum levels of soluble CD26 and CD30 in patients on hemodialysis,” Nephron, vol. 91, no. 2, pp. 215–221, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. W. W. Altermann, G. Schlaf, A. Rothhoff, and B. Seliger, “High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30—a feasible marker for prediction of kidney allograft rejection?” Nephrology Dialysis Transplantation, vol. 22, no. 10, pp. 2795–2799, 2007. View at Publisher · View at Google Scholar
  16. M. Koukoulaki, E. Grispou, D. Pistolas et al., “Prospective monitoring of BK virus replication in renal transplant recipients,” Transplant Infectious Disease, vol. 11, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. H. H. Hirsch and P. Randhawa, “BK polyomavirus in solid organ transplantation,” American Journal of Transplantation, vol. 13, supplement 4, pp. 179–188, 2013. View at Publisher · View at Google Scholar
  18. E. Montecino-Rodriguez, B. Berent-Maoz, and K. Dorshkind, “Causes, consequences, and reversal of immune system aging,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 958–965, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. B. Al-Obaidi, K. H. Abd, H. S. Kadhim, M. A. Habib, A. S. Abdlameer, and H. A. Shamran, “BK polyomavirus and cytomegalovirus co-infections in renal transplant recipients: a single center study,” International Journal of Advanced Research, vol. 3, no. 1, pp. 856–864, 2015. View at Google Scholar
  20. J. Trofe-Clark, T. Sparkes, C. Gentile, V. van Deerlin, D. Sawinski, and R. D. Bloom, “BK virus genotype variance and discordant BK viremia PCR assay results,” American Journal of Transplantation, vol. 13, no. 4, pp. 1112–1113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. H. H. Hirsch, D. C. Brennan, C. B. Drachenberg et al., “Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations,” Transplantation, vol. 79, no. 10, pp. 1277–1286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. H. B. Viscount, A. J. Eid, M. J. Espy et al., “Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy,” Transplantation, vol. 84, no. 3, pp. 340–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Sawinski and S. Goral, “BK virus infection: an update on diagnosis and treatment,” Nephrology Dialysis Transplantation, vol. 30, no. 2, pp. 209–217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Fattovich, F. Vinante, G. Giustina et al., “Serum levels of soluble CD30 in chronic hepatitis B virus infection,” Clinical and Experimental Immunology, vol. 103, no. 1, pp. 105–110, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Haque, T. Chaggar, J. Schafers, C. Atkinson, K. A. McAulay, and D. H. Crawford, “Soluble CD30: a serum marker for Epstein-Barr virus-associated lymphoproliferative diseases,” Journal of Medical Virology, vol. 83, no. 2, pp. 311–316, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Franzese, A. Mascali, A. Capria, V. Castagnola, L. Paganizza, and N. Di Daniele, “Regulatory T cells in the immunodiagnosis and outcome of kidney allograft rejection,” Clinical and Developmental Immunology, vol. 2013, Article ID 852395, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Weimer, C. Süsal, S. Yildiz et al., “Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens,” American Journal of Transplantation, vol. 6, no. 8, pp. 1865–1874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. P. C. Grenzi, É. F. Campos, H. Tedesco-Silva et al., “Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy,” Transplant Immunology, vol. 29, no. 1–4, pp. 34–38, 2013. View at Publisher · View at Google Scholar · View at Scopus